88IV - PR Newswire Asia's news


Abbisko Therapeutics' FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma SHANGHAI , April 1, 2026 /PRNewswire/ -- 31 March 2026, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256) announced that its independently developed, ... 2026-04-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NJ Bio, Inc. and Ajinomoto Bio‑Pharma Services Enter into Collaboration to Strengthen Support for Antibody-Drug Conjugate Development PRINCETON, N.J. and TOKYO , April 1, 2026 /PRNewswire/ -- NJ Bio, Inc. ("NJ Bio"), a leading provider of integrated drug discovery and development services and Ajinomoto Bio‑Pharma Services ... 2026-04-01T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Samsung Biologics completes acquisition of GSK's manufacturing facility in Rockville, Maryland Adds 60,000 liters of drug substance capacity, bringing the total to 845,000 liters Marks Samsung Biologics' geographical diversification and establishes its first U.S. manufacturing presence, expanding ... 2026-03-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Co-PSMA data published in the European Urology journal SYDNEY , March 31, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation ... 2026-03-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
3SBio Announces 2025 Annual Results: Dual Engines of Innovative R&D and Global Collaboration Propel Revenue Past RMB 10 Billion Milestone SHANGHAI , March 31, 2026 /PRNewswire/ -- 3SBio Inc. ( 01530.HK ) today released its 2025 annual results announcement. Fueled by the dual core engines of breakthroughs in innovative R&D and strategic ... 2026-03-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD TAMPA, Fla. , March 31, 2026 /PRNewswire/ -- Concept Medical Inc. (CMI), a global leader in innovative drug-delivery technology across vascular interventions, proudly announces the presentation of ... 2026-03-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
DNV SELECTED TO CERTIFY CLASS D DEVICES FOR LEADING U.S. MANUFACTURER UNDER EU IVDR DNV supports the manufacturer's transition to new regulation with its digital certification platform and transparent, predictable project management. ... 2026-03-31T Biotechnology Computer/Electronics Health Care/Hospital Medical Equipment
Abbisko Therapeutics' FGFR2/3 Inhibitor ABSK061 Receives FDA IND Clearance for Achondroplasia in Children SHANGHAI , March 31, 2026 /PRNewswire/ -- On 30 March, 2026 , Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) announced that the U.S. Food and ... 2026-03-31T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NAVER D2SF Makes Follow-On Investment in Nuvilab, AI Nutrition Analytics Startup SEONGNAM, South Korea , March 31, 2026 /PRNewswire/ -- NAVER D2SF, the corporate venture capital arm of NAVER, has made a follow-on investment in Nuvilab, an AI-powered nutrition analytics healthcare startup. ... 2026-03-31T Biotechnology Computer/Electronics Food/Beverages Health Care/Hospital
Sanyou Milestone \| Recognized as a "Shanghai Municipal Enterprise Technology Center," Further Validating for Innovation Excellence SHANGHAI , March 30, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals has recently been honored as a "Shanghai Municipal Enterprise Technology Center" in recognition of its outstanding technological ... 2026-03-30T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology